Français Register Login

  • All sections
  • A - Human necessities
  • A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
  • A61P 31/14 - Antivirals for RNA viruses

Patent holdings for IPC class A61P 31/14

Total number of patents in this class: 12121

10-year publication summary

169
185
270
377
408
1778
1951
2205
1373
579
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Gilead Sciences, Inc.
2036
126
The United States of America, as represented by the Secretary, Department of Health and Human Services
2851
96
The Regents of the University of California
19918
95
Bristol-myers Squibb Company
4898
84
Centre National de La Recherche Scientifique
10418
76
Katholieke Universiteit Leuven
1191
70
Janssen Pharmaceuticals, Inc.
433
67
Modernatx, Inc.
1263
66
Enanta Pharmaceuticals, Inc.
428
65
Emory University
1626
63
Inserm (institut National de La Sante et de La Recherche Medicale)
3368
57
BioNTech SE
661
54
The Trustees of the University of Pennsylvania
4322
52
Vanderbilt University
1901
50
Shanghai Institute of Materia Medica, Chinese Academy of Sciences
823
48
Board of Regents, The University of Texas System
5793
46
Pfizer Inc.
3387
45
The Board of Trustees of the Leland Stanford Junior University
6408
45
Institut Pasteur
785
45
The Wistar Institute of Anatomy and Biology
450
43
Other owners 10828

  • ipowner home
  • ipqwery home
  • contact us
  • privacy policy
  • terms and conditions
© 2025 IPQwery All rights reserved